Advances in the Management of Prostate Cancer: A Multidisciplinary Approach - On Demand


Advances in the Management of Prostate Cancer: A Multidisciplinary Approach - On Demand Banner



Date & Location
Monday, October 31, 2022, 8:00 AM - Thursday, August 31, 2023, 11:00 PM

Specialties
Specialties - Genetics, Genitourinary Oncology, Pathology, Radiation Oncology

Overview

This multidisciplinary course focuses on the management of prostate cancer from diagnosis through castration resistant disease. This on demand includes lectures, panel discussions, and case presentations addressing topics such as:

  • an overview of systemic therapy: hormonal agents, chemotherapy, targeted therapies, and theranostics;
  • initial risk assessment using routinely available clinical information;
  • genomic classifiers, germline testing, and molecular imaging;
  • risk-based management options for clinically localized prostate cancer including active surveillance, focal therapy, radical prostatectomy, and radiation therapy;
  • defining oligometastatic prostate cancer and multidisciplinary approaches to the management of the local tumor, metastatic sites, and systemic therapy;
  • management of local recurrence after radical prostatectomy and radiation therapy;
  • prevention and management of treatment related toxicities.

On Demand Content

This course is intended for urologists, radiation oncologists, radiologists, medical oncologists, pathologists and other healthcare professionals interested in prostate cancer management. Select the 'Register' tab at the top of this page to purchase this program. Once you have successfully registered, access to the course materials will be available under the 'Course Content' tab.

This on demand program will be available for purchase until May 31, 2023.
Access to the videos and claiming credit will be available until August 31, 2023.

Objectives
  1. Explain the risk assessment of prostate cancer.
  2. Evaluate the selection and management of patients for active surveillance.
  3. Review techniques, performance, and outcomes from radical prostatectomy and radiation therapy for clinically localized prostate cancer.
  4. Review management of oligometastatic prostate cancer.
  5. Discuss management of hormone sensitive metastatic and castration resistant metastatic prostate cancer.

Registration

On Demand Access Fees:

  • Physicians (MDs, PhDs, and DOs): $600
  • Advanced Practice Providers: $450
  • Residents, Fellows, Nurses, and Other Healthcare Providers: $300
  • Industry Professionals: $1,050

Discounts/Promotions

  • A registration discount is available for MSK Alumni and MSK Cancer Alliance to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
  • Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Registration for this MSK CME on demand is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 19.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

'Recorded/Review Date: October 13-15, 2022; Original Release Date: November 18, 2022; Termination Date: August 31, 2023


Keywords: AMA PRA Category 1